MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

RedHill Biopharma Ltd - Company Profile (NASDAQ:RDHL)

Consensus Ratings for RedHill Biopharma Ltd - (NASDAQ:RDHL) (?)
Ratings Breakdown: 7 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $29.43 (167.78% upside)

Analysts' Ratings History for RedHill Biopharma Ltd - (NASDAQ:RDHL)
Show:
DateFirmActionRatingPrice TargetActions
5/3/2016FBR & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016NomuraReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/28/2016HC WainwrightReiterated RatingBuy$33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2016Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2015Ascendiant Capital MarketsLower Price TargetBuy$28.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/29/2015Northland SecuritiesInitiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015MLV & Co.Initiated CoverageBuy$33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha